PRKAR1A
PRKAR1A (protein kinase cAMP-dependent type I regulatory subunit alpha, also known as CNC1, PRKAR1, TSE1 and PKR1) is the type I-alpha regulatory subunit of protein kinase A. It restrains the catalytic subunits until cAMP binds, linking the second messenger to downstream phosphorylation. Browse Assay Genie's current range of PRKAR1A research reagents below, or read on for the biology behind the target.
cAMP is a signalling molecule that governs a wide range of cellular functions, and it acts by activating cAMP-dependent protein kinase, which transduces the signal by phosphorylating different target proteins. PRKAR1A is one of the regulatory subunits of this kinase. The inactive holoenzyme is a tetramer of two regulatory and two catalytic subunits. When cAMP binds, the holoenzyme dissociates into a dimer of regulatory subunits bound to four cAMP and two free, monomeric catalytic subunits.
The PRKAR1A gene encodes a member of the cAMP-dependent kinase regulatory chain family, listed by HGNC in the protein kinase A subunits group. Humans have four different regulatory subunits and three catalytic subunits, and PRKAR1A is one of the four. UniProt annotates the protein at the cell membrane. Several alternatively spliced transcript variants encode two different isoforms. The mouse and rat orthologs are both named Prkar1a, so the PRKAR1A protein can be studied in common rodent models.
The alias TSE1 comes from the discovery of PRKAR1A as a tissue-specific extinguisher, which down-regulates the expression of seven liver genes in hepatoma x fibroblast hybrids. Mutations in the gene cause Carney complex (CNC). The gene can also fuse to the RET protooncogene by rearrangement, forming the thyroid tumour-specific chimeric oncogene PTC2. A nonconventional nuclear localisation sequence has been described, suggesting a role in DNA replication, with PRKAR1A acting as a nuclear transport protein for the second subunit of Replication Factor C (RFC40).
PRKAR1A is a regulatory subunit that holds PKA inactive until cAMP binds, making it central to studies of cAMP-driven phosphorylation.
Mutations in the PRKAR1A gene cause Carney complex, so the protein is a focus for work on this inherited condition.
PRKAR1A can fuse to the RET protooncogene, forming the thyroid tumour-specific chimeric oncogene PTC2.
PRKAR1A acts as a tissue-specific extinguisher of liver genes and may transport RFC40 to the nucleus, informing studies of regulation and replication.
PRKAR1A is a regulatory subunit of cAMP-dependent protein kinase. In the inactive tetramer, two regulatory subunits hold two catalytic subunits. When cAMP binds, the regulatory dimer separates from the free catalytic monomers, which then phosphorylate target proteins. Check the datasheet of any product for its validated reactivity.
PRKAR1A is also called CNC1, PRKAR1, TSE1, PKR1 and Prkar1alpha. Earlier names include tissue specific extinguisher 1 and protein kinase, cAMP-dependent, regulatory, type I, alpha. Alternatively spliced transcript variants encode two different isoforms.
Yes. Mutations in PRKAR1A cause Carney complex. The gene can also fuse to RET by gene rearrangement, producing the thyroid tumour-specific chimeric oncogene PTC2. Mouse and rat both carry an ortholog named Prkar1a.
Other protein kinase A regulatory subunits with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P10644; product specifications from Assay Genie datasheets.